RecruitingNot ApplicableNCT06939192

E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families

E-health-supported Recording of Psychological and Somatic Problems, Risk and Resilience Factors of Premature Born Infants and Their Families and Individualized, Interdisciplinary Stepped-care Approach


Sponsor

University Hospital Tuebingen

Enrollment

120 participants

Start Date

Jan 31, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The app-based diagnostic and support approach with a focus on mental and somatic symptoms is intended to strengthen the resilience of premature born children and families and to identify risk and resilience factors.The overall objective of the study is to improve the post-inpatient care of families with premature born children. The procedure is evaluated by a two-arm design with an experimental group and a TAU group.


Eligibility

Min Age: 28 WeeksMax Age: 34 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Intervention Group (APP) and Treatment as usual-Group (TAU) for people with preterm birth. The study is currently recruiting participants at 1 location. People eligible for this study include aged 28 Weeks to 34 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIntervention Group (APP)

Combination of app-based information and diagnostic screening for parents of premature babies.

OTHERTreatment as usual-Group (TAU)

No intervention. Treatment in the form of usual aftercare service is possible.


Locations(1)

University Hospital Tuebingen

Tübingen, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06939192


Related Trials